Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism

Abstract

BACKGROUND: Oral contraceptives can induce changes in lipid and carbohydrate metabolism similar to those associated with an increased risk of coronary heart disease, including increased serum triglyceride, low-density lipoprotein (LDL) cholesterol, and insulin levels and decreased high-density lipoprotein (HDL) cholesterol levels. In this study, we examined whether modification of the type or dose of progestin in oral-contraceptive preparations diminishes these changes. METHODS: We measured plasma lipoprotein levels and performed oral glucose-tolerance tests in a cross section of 1060 women who took one of nine types of oral contraceptives for at least three months and 418 women who took none. Seven of the contraceptive formulations contained various doses and types of progestin: levonorgestrel in low (150 micrograms), high (250 micrograms), and triphasic (50 to 125 micrograms) doses; norethindrone in low (500 micrograms), high (1000 micrograms), and triphasic (500 to 1000 micrograms) doses; and a new progestin, desogestrel, in one dose (150 micrograms). All seven contained 30 to 40 micrograms of ethinyl estradiol. Two additional formulations contained progestin alone. RESULTS: As compared with controls, women taking combination drugs did not have increased serum total cholesterol levels but did have increases of 13 to 75 percent in fasting triglyceride levels. Levels of LDL cholesterol were reduced by 14 percent in women taking the combination containing desogestrel and by 12 percent in those taking low-dose norethindrone. Levels of HDL cholesterol were lowered by 5 percent and 16 percent by the combinations containing low-dose and high-dose levonorgestrel, respectively; these decreases were due to reductions of 29 percent and 43 percent, respectively, in the levels of HDL subclass 2. The combination pill containing high-dose norethindrone did not affect HDL cholesterol levels, whereas that containing low-dose norethindrone increased HDL cholesterol levels by 10 percent. The desogestrel combination increased HDL cholesterol levels by 12 percent. Levels of apolipoproteins A-I, A-II, and B were generally increased by combination drugs. Depending on the dose and type of progestin, combination drugs were associated with plasma glucose levels on the glucose-tolerance test that were 43 to 61 percent higher than in controls, insulin responses 12 to 40 percent higher, and C-peptide responses 18 to 45 percent higher. Progestin-only formulations had only minor metabolic effects. CONCLUSIONS: The appropriate dose and type of progestin may reduce the adverse effects of oral contraceptives on many metabolic markers of risk for coronary heart disease. Progestin-only formulations or combinations containing desogestrel or low-dose norethindrone were associated wtih the most favorable profiles.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199011153232003

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 3

  1. 1966, Lancet, 2, 799
  2. Sturtevant, 1989, Int J Fertil, 34, 323
  3. Nikkilä EA, Tikkanen MJ, Kuusi T. Effects of progestins on plasma lipoproteins and heparin-releasable lipases. In: Bardin CW, Milgrom E, Mauvais-Jarvis P, eds. Progesterone and progestins. New York: Raven Press, 1983:411–20.

Cited by

See all 418

Metadata

Authors
Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V.
Venue
New England Journal of Medicine
Published
1990-11-15
Volume
323
Issue
20
Pages
1375-1381
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2596242802
Cited by
417
References
38
Citations by year
2026: 5 · 2025: 11 · 2024: 9 · 2023: 12 · 2022: 5 · 2021: 10 · 2020: 3 · 2019: 7 · 2018: 7 · 2017: 13 · 2016: 11 · 2015: 8 · 2014: 9 · 2013: 11 · 2012: 13
FWCI
25.69
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01hd052907-001)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (N01-HD-52907)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
oral contraceptives, levonorgestrel, norethisterone, desogestrel, ethinyl estradiol, lipid metabolism, carbohydrate metabolism, triglycerides, LDL cholesterol, HDL cholesterol, HDL subfractions, apolipoproteins, insulin, glucose tolerance, coronary heart disease risk, women's health, progestin-only contraception
MeSH terms
Adolescent, Adult, Blood Glucose, C-Peptide, Cholesterol, Contraceptives, Oral, Combined, Contraceptives, Oral, Sequential, Ethynodiol Diacetate, Female, Humans, Insulin, Cholesterol, HDL, Cholesterol, LDL, Middle Aged, Norethindrone, Norgestrel, Norpregnenes, Triglycerides, Levonorgestrel, Desogestrel, Progesterone Congeners, Carbohydrate Metabolism, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism. https://app.cochat.ai/papers/10.1056/nejm199011153232003
The paper
Godsland, I. F., Crook, D., Simpson, R., Proudler, T., Felton, C., Lees, B., Anyaoku, V., Devenport, M., & Wynn, V. (1990). The Effects of Different Formulations of Oral Contraceptive Agents on Lipid and Carbohydrate Metabolism. New England Journal of Medicine. https://doi.org/10.1056/nejm199011153232003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.